BOSTON, Mass. — Sempresto, Inc., a medical device company developing smartphone-integrated rescue drug delivery systems, has acquired all patents and related physical and digital assets from inventor Steven A. Friedman. His innovations, which center on new mechanisms and enhanced safety features for mobile device-integrated autoinjectors, will serve as core components for Sempresto’s next generation of drug delivery platforms. The acquisition expands the company’s intellectual property portfolio in cellphone-mounted and connected drug delivery technologies.
“Friedman’s broad and innovative platform supports our strategic objectives and enhances our leadership position in cellphone-based drug delivery,” said Elizabeth Reczek, PhD, CEO of Sempresto. “By integrating his work into our expanding portfolio, we are accelerating development of technologies that will redefine how patients access life-saving medications.”
“I am pleased that my work, with its focus on safety and portability of lifesaving medications, will be advanced by Sempresto,” said Steven A. Friedman. “The leadership team—with their deep expertise and personal experience with severe allergies—are the right group to bring this vision forward and ensure it reaches the patients who need it.”
With the acquisition, Sempresto strengthens its leadership in developing smartphone-mounted, always-connected autoinjectors designed to improve patient readiness and support individuals living with severe allergies and other acute conditions.
